Jab hope for rheumatoid arthritis

[liebereuch]

A monthly injection could halt rheumatoid arthritis (RA) in half of all patients, trial data suggests.

The antibody drug tocilizumab works in conjunction with an existing treatment, methotrexate, to stop the condition in which the body attacks its own joints. The drug, which will be sold under the brand name RoActemra by Roche, is awaiting approval

Comments

[nevboo]

Oh! Another interesting science bit appeared while I was commenting!

I really enjoyed "Bad Science" where Ben Goldacre talked about proper clinical trials. I wish he'd stuck in a diagram like this too!

[liebereuch]

Yeah, just a shame some people in the business still don't even know it ;-)